KAPA Kairos Pharma Ltd: Bozor kapitallashuvining balans qiymatiga nisbati

kairospharma.com (KAPA) korporativ emblemasi va logotipi

Kairos Pharma Ltd (KAPA) kompaniyasining bozor qiymati grafigi, xarajatlarni minimallashtirish uchun ishlab chiqarish va sinovlarni autsorsing qilishga tayanadigan aktivning narxlar dinamikasini aks ettiradi. Masshtablashish modeli huquqlarni sanoat gigantlariga keyinchalik sotish uchun patentlar yaratishga asoslangan bo'lib, ko'rsatkich 0.38 darajasida turibdi. O'sish istiqbollari neoplazma qarshiligiga qarshi kurashish yo'llarini izlash bilan bog'liq, garchi erta bosqichdagi ishlanmalarning tez-tez uchraydigan tebranishlari allaqachon narxga kiritilgan bo'lsa-da.

Kairos Pharma (KAPA) - Bozor kapitallashuvining balans qiymatiga nisbati 17.09.2024dan 29.10.2026gacha

Kairos Pharma Ltd (KAPA) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- aksiya kursi va ekspertlarning narx prognozi:
Aksiya narxi kairospharma.com|KAPA - Tahlilchilar konsensus prognozi
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
Bozor kapitallashuvi Kairos Pharma Inc|KAPA - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Kairos Pharma|KAPA - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati kairospharma.com|KAPA - Biznesning umumiy aktivlari
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Umumiy qarzning kapitalga nisbati Kairos Pharma Ltd|KAPA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati kairospharma.com|KAPA - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Kairos Pharma Inc|KAPA - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Kairos Pharma
Kompaniyaning har tomonlama tahlili:Kairos Pharma Ltd
Kairos Pharma Ltd yetakchi tovari

Kairos Pharma Ltd (KAPA) onkologik qarshilikni yengishga investitsiyalar kiritmoqda, bu esa uning aktivlar qiymatini innovatsion istiqbollarga bog'liq qiladi. Bozor qiymatining buxgalteriya qiymatiga nisbati ko'rsatilgan ushbu grafik birja baholovi va haqiqiy kapital o'rtasidagi farqni vizuallashtiradi. Koeffitsient bozor kapitalizatsiyasini sof kapitalga bo'lish orqali hisoblanadi. Yuqori qiymatlar haddan tashqari ortiqcha kutishlar signalini beradi, past qiymatlar esa aktivlarning yetarlicha baholanmaganligini ko'rsatadi. Bu aktiv uchun optimal kirish nuqtasini aniqlashga yordam beradi.

Kairos Pharma Ltd kimlar bilan raqobatlashadi

ONC: Bozor kapitallashuvining balans qiymatiga nisbati|halozyme.com (HALO) - Bozor kapitallashuvining balans qiymatiga nisbati|RVMD (Revolution Medicines, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International (AAPG)|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati UroGen Pharma Corp (URGN)|Bozor qiymatining balans qiymatiga nisbati Bicara Therapeutics Inc. BCAX|PSNL: Kapitallashuvning balans qiymatiga nisbati|Erasca - Bozor kapitallashuvining balans qiymatiga nisbati|Delcath Systems Inc (DCTH) - Kapitallashuvning sof aktivlarga nisbati|YMAB: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Aura Corp (AURA)|Bozor qiymatining balans qiymatiga nisbati Candel Therapeutics Inc.|ARAY: Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati SLS (SELLAS Life Sciences)|ACTU (Actuate Therapeutics Inc.) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CTOR (Citius Oncology, Inc)|HURA - Kapitallashuvning sof aktivlarga nisbati|TARA: Kapitallashuvning sof aktivlarga nisbati|FATE - Bozor kapitallashuvining balans qiymatiga nisbati|aadibio.com (WHWK) - Bozor qiymatining balans qiymatiga nisbati|TScan Therapeutics, Inc. - Balans qiymatiga nisbatan bozor qiymati|CSBR (Champions Oncology Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti XBiotech USA XBIT|Bozor qiymatining balans qiymatiga nisbati CEL-SCI Corporation (CVM)|Bozor kapitallashuvining balans qiymatiga nisbati ostherapies.com (OSTX)|Bozor kapitallashuvining balans qiymatiga nisbati RADX (Radiopharm Theranostics)|Bozor kapitallashuvining balans qiymatiga nisbati Artiva Biotherapeutics Inc. ARTV|Adlai Nortye Limited - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Veru Corporation VERU|Tempest Therapeutics (TPST) - Bozor qiymatining balans qiymatiga nisbati|Xilio Therapeutics - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Renovaro Biosciences|Bozor qiymatining balans qiymatiga koeffitsiyenti Mural Bio MURA|Bozor qiymatining balans qiymatiga nisbati OnKure Therapeutics Inc (OKUR)|Balans qiymatiga nisbatan bozor kapitallashuvi w2.cytomed.sg|Curis - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati APLM|THAR - Bozor qiymatining balans qiymatiga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi ADVB|GNPX: Bozor kapitallashuvining balans qiymatiga nisbati|Calidi Biotherapeutics, Inc. - Balans qiymatiga nisbatan bozor qiymati|SBFM (Sunshine Biopharma) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Xenetic Bio|Bozor qiymatining balans qiymatiga nisbati Salarius Pharmaceuticals, Inc. (SLRX)|PPBT (Purple Biotech Ltd) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati American Oncology Network, Inc. AONC|BGNE - Kapitallashuvning sof aktivlarga nisbati|Checkpoint Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|ELEV - Bozor kapitallashuvining balans qiymatiga nisbati|ICAD (icadmed.com) - Kapitallashuvning sof aktivlarga nisbati|Ikena Oncology - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Notable Labs Inc.|Bozor qiymatining balans qiymatiga nisbati VIRX|Kapitallashuvning sof aktivlarga nisbati MOR (MorphoSys AG)|Bozor kapitallashuvining balans qiymatiga multiplikatori NAYA|Bozor kapitallashuvining balans qiymatiga nisbati AAPGV (Ascentage Pharma)